baber/WOPTO huggingface dataset:
Patent CA-2338806-A1 (CA)
Title: Composition for freshening nostrils and sinus cavities
Inventor: FUST CHARLES A
IPC: A61K31/352
Filed: 1999-07-28
Abstract: A composition for freshening nostrils and sinus cavities is disclosed for masking or eliminating objectionable odors in the breath. The composition is typically administered from a squeeze or pump-type bottle or the like and includes a carrier such as saline solution and a masking agent such as oil of peppermint or other flavoring.
Patent CA-2344145-A1 (CA)
Inventor: BAWENDI MOUNGI G
IPC: H01L33/00
Filed: 1999-09-17
Abstract: L'invention concerne un nouveau dispositif de codage, des compositions associées utilisées et des procédés permettant de déterminer la source, l'emplacement et/ou l'identité'un article ou d'un composant particulier. L'invention concerne notamment une collection d'au moins un effectif de populations de nanocristaux semi-conducteurs ayant des émissions spectrales caractéristiques, pour <= suivre >= la source ou l'emplacement d'un article d'intérêt ou pour identifier un tel article. Les nanocristaux utilisés dans les compositions selon l'invention peuvent être choisis pour émettre une longueur d'onde souhaitée afin de produire une émission spectrale caractéristique dans des largeurs spectrales étroites, et avec une caractéristique de ligne symétrique, quasi gaussienne, par le changement de la composition et des dimensions du nanocristal semi-conducteur. On peut en outre faire varier l'intensité de l'émission à une longueur d'onde caractéristique donnée, ce qui permet d'utiliser des programmes de codage d'ordre binaire ou supérieur.
Patent CA-2344485-A1 (CA)
Inventor: WOODS CAREY P
IPC: B44C5/04
Filed: 1999-09-07
Abstract: A framing device (10), used for displaying items such as photographs, certificates and the like, includes a sheet of translucent material (12) having an outward side (14) and an inward side (16) and a common continuous edge (20). An adhesive (22) is applied along the inward side (16) adjacent to the continuous edge (20) in such a manner that a portion of such edge (20) remains adhesive-free. A sheet of backing material (18) and a second side (32) and the first side (30) of such foam is postitionally secured by the adhesive (22) and with respect to the translucent material (12). And a release liner (34) is attached to the second side (32) of the backing material (18). The adhesive-free portion of the edge (20) and the sheet of backing sheet (18) define a slot permitting insertion and removal of an item to be displayed.
Patent CA-2350595-A1 (CA)
Inventor: WANG XUAN-QI
IPC: F15C5/00
Filed: 1999-11-16
Abstract: The present disclosure describes a Parylene micro check valve (10) including  a micromachined silicon valve seat (15) with a roughened top surface to which a membrane cap (20) is anchored by twist-up tethers (25). The micro check valv e is found to exhibit low cracking pressure, high reverse pressure, low revers e flow leakage, and negligible membrane-induced flow resistance when used as a  valve over a micro orifice through which flow liquid and gas fluids.
Patent CA-2353123-A1 (CA)
Title: Method of providing stack memory in an operating system with stack memory constraints
Inventor: MERCER RONALD G
IPC: G06F12/02
Filed: 2001-07-13
Abstract: The present invention is directed at a method of providing stack memory in an operating system with stack memory constraints. During operation, software modules executing on the operating system may require more than the allotted stack memory, therefore, in order to avoid stack overflow, more stack memory is required. Therefore, in accordance with a preferred embodiment of the present invention, upon initial execution of the software module, a request is sent to the operating system for the provision of more stack memory. The operating system then returns an address location within the operating system's memory where more stack memory may be provided.  A new stack pointer value corresponding to the new address location is stored in the stack pointer value register and the existing stack pointer value is then stored in a pre-determined register. After the software module has finished executing, the existing stack pointer value stored in the predetermined register is retrieved and replaces the stack pointer value in the stack pointer value register.
Patent CA-2355526-A1 (CA)
Inventor: VAN RHIENEN ALPHONS
IPC: A47B47/00
Filed: 2001-08-17
Abstract: A system for assembling a modular shelving unit and the like includes first panels and at least one second panel. All of the panels have a substantially hollow resin material construction. The first panels are to be used as vertical supports for holding the second panel as a horizontal platform within the unit. The system further includes a panel reinforcement comprising a reinforcing brace and brace fasteners. The reinforcing brace is of generally the same length as and insertable within the second panel. The brace fasteners are fittable through the first panels to both secure the brace interiorly of and to clamp the second panel between the first panels when the unit is assembled.
Patent CA-2361763-A1 (CA)
Title: Computer system identification
Inventor: MI JAMES Q
IPC: H04L9/32
Filed: 2000-01-12
Abstract: A computer system (10) includes an interface (31) and a processor (200). The interface (31) is adapted to receive a request from another computer system for identification of the first computer system. The adapter (31) also furnishes a hash value that identifies the first computer system to the other computer system. The processor (200) is coupled to the interface (31) and is adapted to encrypt an identifier (30) that identifies the first computer system with a key (34) associated with the other computer system to provide the hash value (32).
Patent CA-2362549-A1 (CA)
Inventor: CHATTERJEE SUBROTO
IPC: A61K38/46
Filed: 2000-02-23
Abstract: Compositions and methods are provided for modulating serum cholesterol in a subject mammal. In one aspect, the invention features novel anti-lipemic drugs that include at least one identified effector of the Low Density Liproprotein (LDL) receptor and at least one identified serum cholesterol inhibitor. In a particular aspect, the drugs include one identified sphingolipid or protein modifying same linked to one identified serum cholesterol inhibitor.  Additionally provided are methods for identifying anti-lipemic drugs capable of modulating the LDL receptor and specifically SREBP-1 maturation, including assays designed to identify pharmacoligical drugs capable of stabilizing or reducing serum cholesterol levels in a mammal and particularly a human patient.
Patent CA-2363106-A1 (CA)
Title: Mdm interacting protein and methods of use thereof
Inventor: SCHULZ VINCENT PETER
IPC: A61P35/00
Filed: 2000-02-23
Abstract: Disclosed are complexes of the MDM2 protein and a novel MDM2-interacting protein (MDMIP). Also disclosed are nucleic acids encoding the MDMIP polypeptide, as well as derivatives, fragments, analogs and homologs of the MDMIP polypeptide and MDM2-MDMIP complexes.
Patent CA-2364234-A1 (CA)
Title: Short range communication system
Inventor: DE PAEPE KRISTIAAN
IPC: G06K7/10
Filed: 2000-12-13
Abstract: Short range communication systems and techniques are described. In an implementation an interrogator held near a person interrogates multiple transponders and receives information separately fromthe transponders. The interrogator and/or the transponders may be held in an article of clothing or in a personal effect of the person. The transponders may transmit identifying information and/or information associated with the states of the articles of clothing or personal effects of the person. Such a system enables the clothes worn by a person to communicate with a plurality of items and obtain useful information. In addition, a network system may be configured so that any particular transponder may communicate with another transponder or group of transponders of other locales to activates functions, cause actions or otherwise share data and/or information.
Patent CA-2364650-A1 (CA)
Title: Proteines humaines secretees (50)
Inventor: ROSEN CRAIG A
IPC: A61K48/00
Filed: 2000-03-09
Abstract: Cette invention concerne 50 nouvelles protéines humaines sécrétées et des acides nucléiques isolés renfermant des régions de codage des gènes codant pour de telles protéines. L'invention concerne également des vecteurs, des cellules hôtes, des anticorps et des méthodes recombinantes permettant de produire des protéines humaines sécrétées. De plus, l'invention s'intéresse à des méthodes diagnostiques et thérapeutiques utiles pour le diagnostic et le traitement de troubles en rapport avec ces nouvelles protéines humaines sécrétées.
Patent CA-2365938-A1 (CA)
Title: Method of reducing slags in size and device for carrying out said method
Inventor: EDLINGER ALFRED
IPC: C21B3/04
Filed: 2000-04-05
Abstract: The invention relates to a method and to a device for reducing slags in size  by melting the slags and then spraying and granulating them in a cooling chamber. According to the inventive method, the solid slags are molten in a pressure-proof closable melt cyclone and the molten slags are conveyed directly from the melt cyclone to a cooling chamber, said cooling chamber having a lower pressure than the melt cyclone. The inventive device comprise s a melt cyclone with an outlet that enlarges from the narrowest point towards  the orifice to which a cooling chamber is connected, especially flanged, so as to withstand the pressure.
Patent CA-2367590-A1 (CA)
Title: In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
Inventor: STORKUS WALTER
IPC: A61K39/00
Filed: 2000-03-30
Abstract: Antigen-specific T-cells prepared by culturing T-cells in formulations comprising combinations of DCs and either tumor cells or virally infected cells are disclosed. These formulations generally comprise hybridoma of at least one dendritic cell fused to either at least one tumor cell or at least  one virally infected cell, or co-cultures of dendritic cells and either tumo r cells or virally infected cells. The resulting T-cells can then be used in immunotherapy methods through adoptive transfer of autologous antigen-specif ic T-cells into patients using well-established techniques, as agents to identi fy tumor antigens, and to establish animal models.
Patent CA-2368458-A1 (CA)
Title: Propynyl uracils
Inventor: NIRCHIO PETER C
IPC: C07D405/04
Filed: 2000-03-16
Abstract: The present invention provides compounds comprising propynyl uracils having formula (I) wherein R1 is hydrogen, chlorine, bromine, iodine, fluorine, -CN , substituted or unsubstituted linear or branched C1-C4 alkyl, -NO2, methoxy, ethoxy, n-propoxy, or iso-propoxy; R2 is iodine or bromine; and R3 is propynyl, 3-iodopropynyl, 3-bromopropynyl, substituted or unsubstituted 2- furanyl, substituted or unsubstituted 3-furanyl, substituted or unsubstitute d 2-pyrrolidinyl, substituted or unsubstituted 3-pyrrolidinyl, D-ribose, or deoxyribose. Another embodiment of the invention encompasses propynyl uracil s having formula (II) wherein R4 is hydrogen, chlorine, bromine, iodine, fluorine, -CN, substituted or unsubstituted linear or branched C1-C4 alkyl, - NO2, methoxy, ethoxy, n-propoxy, or iso-propoxy; R5 is hydrogen or propynyl;  and R6 is iodine or bromine. Also, methods of preparing these propynyl uraci ls are provided. The propynyl uracils of the present invention are useful as biocides, including, but not limited to, bactericides, fungicides, and preservatives.
Patent CA-2370005-A1 (CA)
Inventor: VADEHRA DARAM VIR
IPC: A23C9/152
Filed: 2000-02-28
Abstract: A calcium-fortified milk or dairy-based product comprising a calcium source and a food-grade polyphosphate having at least six phosphate groups.
Patent CA-2370442-A1 (CA)
Inventor: GELLISSEN GERD
IPC: C12N15/61
Filed: 2000-04-27
Abstract: The invention relates to a nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity and derivative s thereof, whereby the derivatives have at least 10 % of the chorismate mutase  activity of the chorismate mutase, according to the identification number of  the SEQ ID NO:2. The invention further relates to vectors containing nucleic  acid molecules, to host cells comprising nucleic acid molecules and their us e in methods for producing polypeptides with chorismate mutase activity. The invention also relates to the polypeptides with chorismate mutase activity a nd antibodies which specifically recognise the same. In addition, the invention  relates to methods for producing auxotrophic yeast strains using the nucleic  acid molecules and to the preparation of the yeast strains. The invention al so relates to the use of yeast strains together with the inventive vectors in methods for the recombinant expression of heterologous genes which allow the  transformants to be easily selected by functional complementation.
Patent CA-2372877-A1 (CA)
Inventor: LANKHOF JOHN PETER
IPC: A61F13/515
Filed: 2000-05-09
Abstract: The present invention provides an absorbent article which combines a hydrophobic topsheet with a good liquid acquisition performance. The absorbent article of the present invention comprises a topsheet, a backsheet, a liquid storage structure intermediate the topsheet and the backsheet, and a liquid handling structure intermediate the topsheet and the liquid storage structure. The topsheet of the present invention has a liquid retention of less than 150 mg for a test liquid having a surface tension of 33mN/m.      The liquid handling structure of the present invention has a basis weight to uncompressed caliper ratio of less than 100 grams per square meter per millimeter. The topsheet of the present invention may comprise a fiber coating such as fluoropolymers in order to lower the contact angle of the topsheet.
Patent CA-2372884-A1 (CA)
Title: Automated node restart in clustered computer system
Inventor: THAYIB KISWANTO
IPC: H04L69/40
Filed: 2002-02-21
Abstract: An apparatus, program product and method initiate a restart of a node in a clustered computer system using a member of a clustering group that resides on a different node from that to be restarted. Typically, a restart operation is initiated by the member in response to a membership change message sent by another group member that is resident on the node to be restarted, with an indicator associated with the membership change message that indicates that a restart should be initiated. Typically, the restart is implemented in much the same manner as a start operation that is performed when a node is initially added to a cluster, with additional functionality utilized to preclude repeated restart attempts upon a failure of a prior restart operation.
Patent CA-2373295-A1 (CA)
Inventor: STROMMER GERA
IPC: A61B5/352
Filed: 2000-05-18
Abstract: System (100) includes a position, and orientation processor (102), a super imposing processor (104), a sensor interface (106), a main sensor (110), an auxiliary sensor (112), a 3D electromagnetic field generator (108), an image interface (116), a3D database (120), and a display unit (114). It is noted that system (100) can include additional 3D electromagnetic field generators.
Patent CA-2375140-A1 (CA)
Title: System and method for representing and controlling a production printing workflow
Inventor: HANSEN DAVID R
IPC: B41J29/38
Filed: 2001-05-16
Abstract: A system and method for managing production printing workflow (100) is disclosed. The system includes workflow management software which manages and facilitates the procedural stages of the workflow including job origination (102), job preparation (106), job submission (104) and job fulfillment (110). The workflow management software provides an integrated object oriented interface which visually reflects and interacts with the workflow.
Patent CA-2375223-A1 (CA)
Title: Explosif en emulsion
Inventor: SUJANSKY VLADIMIR
IPC: C06B47/14
Filed: 2000-06-16
Abstract: L'invention concerne une composition d'explosif en émulsion comprenant un explosif en émulsion et un agent de soufflage. Dans le contexte de la présente invention, l'agent de soufflage est un composé, ou un mélange de composés, pouvant réduire l'énergie efficace relative globale de l'explosif en émulsion et donnant des produits gazeux lors de sa combustion/détonation. Des composés d'ammonium inorganiques ou organiques, des acides aminés, des amides ne contenant pas d'ammonium, des carbonates et des nitrates, constituent des exemples d'agents de soufflage adaptés.
Patent CA-2375773-A1 (CA)
Inventor: MELLS BRADLEY
IPC: H04B10/64
Filed: 2000-06-09
Abstract: A method and apparatus (10) are provided for transmitting (12, 14) and receiving (24, 26) multiple RF/microwave subcarriers on a single optical wavelength over an optical link. The method includes the steps of modulating a plurality of RF/microwave subcarrier frequencies with a respective communication signal and modulating an optical carrier wave with the plurality of modulated RF/microwave subcarrier frequencies. The method further includes the steps of detecting the plurality of RF/microwave subcarriers of the optical carrier wave and mixing (102) those subcarriers with a first local oscillator (LO) frequency to create a new heterodyne IF frequency above the highest frequency component of the modulated signal spectrum of the detected subcarriers, filtering an RF/microwave subcarrier frequency of the plurality of detected RF/microwave subcarriers utilizing a bandpass filter (106) at an IF center frequency of the new IF frequency and mixing the filtered RF/microwave subcarrier with a second local oscillator (LO) (108) frequency to derive a difference frequency at a desired center frequency for propagation over the subsequent network element.
Patent CA-2375834-A1 (CA)
Title: Process for making taxane derivatives
Inventor: DANIEWSKI WLODZIMIERZ
IPC: C07D263/06
Filed: 2002-03-11
Abstract: The present invention provides a novel semi-synthetic method of producing a variety of novel taxane derivatives. The method involves the reaction of a phenylisoserine derivative with a suitably blocked Baccatin III derivative to produce a taxane substrate that may be further modified to form Pactitaxel and other potentially useful taxane derivatives.
Patent CA-2376158-A1 (CA)
Title: Use of selective estrogen receptor modulators in the manufacture of medicaments for treating and/or suppressing weight gain
Inventor: MARTEL CELINE
IPC: A61K31/445
Filed: 2000-07-05
Abstract: Novel methods for the medical treatment and/or prevention of obesity, abdominal fat, and insulin resistance in susceptible warm-blooded animals including humans involves the administration of selective estrogen receptor modulators (SERMs). A combination of a SERM with an amount of estrogen or a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-ene-3b,17b - diol and compounds converted in vivo to one of the foregoing precursors or estrogen is also disclosed.
Patent CA-2376239-A1 (CA)
Title: Refastenable absorbent article
Inventor: BRUEMMER-PRESTLEY MARY ANNE
IPC: A41B9/12
Filed: 2000-08-23
Abstract: A refastenable disposable absorbent article is disclosed having a front portion, a back portion and a crotch portion. The crotch portion connects the front portion to the back portion. The front portion has a central section including first and second side edges.  First and second lateral sections are releasably attached to the central section and each lateral section has an outward edge. The front portion also has a first end and a second end. The back portion has first and second side edges and first and second ends. The back portion is divided into a first section and a second section. The first section has a length L2 measured perpendicularly from the first end of the back portion to a line drawn parallel thereto. Multiple elastic strands extend transversely across the first section from the first side edge to the second side edge. The second section has a length L3 measured perpendicularly from the second end to the line drawn parallel to the first end whereby a ratio L2/L3 is established which ranges from between about 0.1 to about 2. Each of the outward edges of the first and second lateral sections of the front portion are secured to one of the first and second side edges of the back portion to form a pant-like article having a waist opening and a pair of leg openings.
Patent CA-2376480-A1 (CA)
Title: Fiber optic multitasking probe
Inventor: WALSH DAVID
IPC: G01N21/64
Filed: 2000-06-09
Abstract: A multitasking optical fiber probe for collecting dosimeter information from  more than one position in a sample. The basic principle of the present invention involves using one or more different sensor zones along the length  of the fiber each with a different photoactive constituent having a sufficiently unique emission spectra (spectral or temporal) to enable deconvolution of the emission spectra by the computer and therefore correlation of the detected parameter with the position of the sensor zone along the length of the optical fiber. In the broadest form of the invention  the probe is embodied by only one sensor zone located at some point along th e length of the fiber spaced away from the end face of the fiber. Probes are provided in which multiple sensor zones are disposed along the length of the  fiber and photoactive constituentswith sufficiently unique emission spectra (intensity and/or spectral shape which convey the optical information) are used in the different sensor zones so that the different spectra can be deconvoluted so that the contributions from the various etch zones can be distinguished. More than one different photoactive constituent could be incorporated into a single sensor zone for measuring several factors in the vicinity of the sensor zone. In photodynamic therapyapplications the probe i s isotropic in response and can be employed for all light (300 to 900 nm) base d medical diagnostics and therapeutics. As an extension the probe can include photosensitiser and molecular oxygen concentrations dosimetry to be used for  photodynamic therapy (PDT) treatment monitoring, dosimetry and planning utilizing a mathematical model describing tissue response to PDT.
Patent CA-2381269-A1 (CA)
Title: Cartridge assembly packaging
Inventor: CARRINGTON JULIAN L III
IPC: A61M5/24
Filed: 2000-09-11
Abstract: There is provided a package for enclosing a cartridge assembly including a cartridge pre-filled with medicament. The package comprises (1) a tube havin g a first open end, a second closed end and a cylindrical wall defining a holl ow interior chamber in communication with said ends for receiving said cartridg e assembly, (2) a cover for covering said first open end of said tube; and (3)  a first structure for securing said cover to said tube. The tube is made of clear plastic. The tube cover is substantially cylindrically shaped. The plu g is positioned within the interior chamber of said tube adjacent the second e nd thereof for protecting against access to the medicament in the cartridge through the distal end of said cartridge. The plug includes a top wall and a n annular side wall extending from said top wall for engaging the inside surfa ce of said tube. The plug is made of aluminum. The second end has portion that is bent around annular wall of said plug. The bent portion extends in a directi on substantially parallel to said cylindrical wall. The first structure is a label that includes a tamper indication element for indicating whether a person has attempted access to the contents of the tube adjacent the first open end of said tube. The tamper element is a serrated edge, whereby when a  user twists said cover, said label tears along the serrated edge thereby leaving jagged edges indicating tampering.